(Q54544255)
Statements
Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study). (English)
1 reference
1 reference
E Aranda
1 reference
J L Manzano
1 reference
F Rivera
1 reference
M Galán
1 reference
M Valladares-Ayerbes
1 reference
M J Safont
1 reference
M J Mendez
1 reference
A Irigoyen
1 reference
A Arrivi
1 reference
J Sastre
1 reference
9 December 2011
1 reference
23
1 reference
7
1 reference
1919-1925
1 reference
Identifiers
1 reference